Abstract

After 10+years of Global research on Indian solution to global problems via path breaking innovations, Dr. Saharan has invented Receptol® oral spray, which will enable people to lead longer & healthier lives via building body‟s own immune system naturally, through state of the art US Product patented technology. Radha108 Nanopeptides, isolated from mammalian colostrum with antiviral and immnomodulator activity that fully treated Asthma, Allergy,HIV & 48 other chronic diseases approved by US PTO( U.S. Patent No. 9,249,188 & 8,518,454 B2) under controlled clinical studies in US, Africa & India. Radha108 functions as a molecular signaling device which works through receptors on target cell surfaces. The mode of action of Receptol® is based on API Radha 108 Nano-informational peptides proteins which are active in mitigating cell fusion & docks on Gp120, 180, 160 receptor CD4, CD8 on the cell surface closing entry of virus like foreign antigen and allergens & get absorbed in the blood through buccal mucosa crossing BBB. Radha108 promotes differentiation of B cells, maturation of macrophages and monocytes & Stimulates production of cytokines IL-1 to IL-11, TNF-α, INF–γ & maturation of immature thymocytes into either helper or suppressor T cells that helps building body's immune system strongly to fight any infection and immune disorders like Asthma, Allergy, URTI, Carcinomas and Type 2 diabetes saving 100s of Billions of $ that are spent in treating such ailments with little or no efficacy. Receptol® is clinically proven through global clinical trials in the USA, Africa & India using worst case scenario for immune disorder like AIDS patients, who were fully treated within one year. Radha108 is very effective and safe among cases with indications like HIV, Swine flu, Allergy, Asthma, Arthritis, Diarrhea, Fever, Fatigue-Malaise, Anemia, Endometriosis.